Truist raises UnitedHealth target to $500 as bullish outlook grows

1 min read | Published on 17 Jul 2026, 07:26 PM |Updated on 17 Jul 2026, 08:06 PM

Reviewed by

Radhika SScanX News Team

Key Highlights

Truist Securities analyst David Macdonald maintained a Buy rating on UnitedHealth Group and raised the price target to $500 from $480. This follows similar bullish actions by RBC Capital, which raised its target to $478, and UBS, which lifted its target to $490, all pointing to sustained operational strength.

*this image is generated using AI for illustrative purposes only.

Truist Securities has increased its price target for UnitedHealth Group to $500, citing a positive outlook for the healthcare giant. Analyst David Macdonald maintained a Buy rating on the stock while lifting the target from $480. This adjustment aligns with a broader bullish sentiment from major financial institutions, including RBC Capital and UBS, which also recently revised their targets upward ahead of the company's next earnings report.

Rating and Price Action

The revised targets from multiple firms suggest sustained confidence in UnitedHealth Group's operational strength and stock performance. RBC Capital analyst Ben Hendrix maintained an Outperform rating and raised the price target to $478 from $463. Similarly, UBS analyst A.J. Rice kept a Buy rating and increased the target to $490 from $460.

Firm	Analyst	Rating	Previous Price Target	New Price Target
Truist Securities	David Macdonald	Buy	$480	$500
RBC Capital	Ben Hendrix	Outperform	$463	$478
UBS	A.J. Rice	Buy	$460	$490

The collective upgrades reflect a positive consensus among major financial institutions regarding the company's valuation trajectory.

What specific operational metrics or growth drivers are analysts expecting UnitedHealth to highlight in the upcoming earnings report?

How might UnitedHealth's performance influence the broader healthcare sector's valuation trends in the near term?

What potential risks, such as regulatory changes or competitive pressures, could offset the current bullish sentiment?

UnitedHealth stock returns 14.89% annually over 15 years

0 min read | Published on 17 Jul 2026, 03:08 AM |Updated on 17 Jul 2026, 03:08 AM

Reviewed by

Radhika SScanX News Team

Add as a preferred
source on Google

Key Highlights

UnitedHealth Group delivered a 14.89% average annual return over the last 15 years, outperforming the market by 2.75%. A $1000 investment from 15 years ago is now worth $8,118.50. The company's current market capitalization stands at $385.96 billion.

*this image is generated using AI for illustrative purposes only.

UnitedHealth Group has outperformed the market over the past 15 years by 2.75% on an annualized basis, producing an average annual return of 14.89%. The company currently holds a market capitalization of $385.96 billion. This performance highlights the impact of compounded returns on long-term investment growth.

Investment Growth Analysis

An investor who purchased $1000 of UnitedHealth Group stock 15 years ago would see a significant increase in value today. Based on a current price of $425.00, that initial investment has grown to $8,118.50.

Key Financial Metrics

Metric	Value
Average Annual Return	14.89%
Market Outperformance	2.75%
Current Market Capitalization	$385.96 billion
Current Share Price	$425.00

The data illustrates how compounded returns can substantially increase cash growth over an extended period. The consistent outperformance relative to the market underscores the stock's long-term value appreciation for shareholders.

Can UnitedHealth Group maintain its 14.89% average annual return over the next decade given current market conditions?

How might regulatory changes in the healthcare sector impact UnitedHealth's future growth trajectory?

What are the key risks that could disrupt the company's compounded returns moving forward?